Literature DB >> 16839880

TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

Karim Bensaad1, Atsushi Tsuruta, Mary A Selak, M Nieves Calvo Vidal, Katsunori Nakano, Ramon Bartrons, Eyal Gottlieb, Karen H Vousden.   

Abstract

The p53 tumor-suppressor protein prevents cancer development through various mechanisms, including the induction of cell-cycle arrest, apoptosis, and the maintenance of genome stability. We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels. These functions of TIGAR correlated with an ability to protect cells from ROS-associated apoptosis, and consequently, knockdown of endogenous TIGAR expression sensitized cells to p53-induced death. Expression of TIGAR may therefore modulate the apoptotic response to p53, allowing survival in the face of mild or transient stress signals that may be reversed or repaired. The decrease of intracellular ROS levels in response to TIGAR may also play a role in the ability of p53 to protect from the accumulation of genomic damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839880     DOI: 10.1016/j.cell.2006.05.036

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  839 in total

Review 1.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

2.  Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.

Authors:  Cen Zhang; Meihua Lin; Rui Wu; Xiaowen Wang; Bo Yang; Arnold J Levine; Wenwei Hu; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

3.  STAT3 can serve as a hit in the process of malignant transformation of primary cells.

Authors:  M Demaria; S Misale; C Giorgi; V Miano; A Camporeale; J Campisi; P Pinton; V Poli
Journal:  Cell Death Differ       Date:  2012-03-09       Impact factor: 15.828

4.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Authors:  Pierre-Jacques Hamard; Dana J Lukin; James J Manfredi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 5.  Cellular metabolism and disease: what do metabolic outliers teach us?

Authors:  Ralph J DeBerardinis; Craig B Thompson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

6.  NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration.

Authors:  Claudio Mauro; Shi Chi Leow; Elena Anso; Sonia Rocha; Anil K Thotakura; Laura Tornatore; Marta Moretti; Enrico De Smaele; Amer A Beg; Vinay Tergaonkar; Navdeep S Chandel; Guido Franzoso
Journal:  Nat Cell Biol       Date:  2011-08-28       Impact factor: 28.824

Review 7.  Regulation of cancer metabolism by O-GlcNAcylation.

Authors:  Zhonghua Li; Wen Yi
Journal:  Glycoconj J       Date:  2013-12-10       Impact factor: 2.916

Review 8.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

Review 9.  A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer.

Authors:  José M Cuezva; María Sánchez-Aragó; Sandra Sala; Amaya Blanco-Rivero; Alvaro D Ortega
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

10.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.